The main patent on Advair (fluticasone+salmeterol) expired as long ago as 2010, while the patent on GSK’s Diskus inhaler expired ... a significantly discounted list price, we will demonstrate ...

The FTC warned in September that it may consider legal action against companies who list new patents ... Boehringer Ingelheim, and GSK also announced commitments to cap inhaler out-of-pocket ...

Animal testing remains widespread, but the long history of campaigning against it has made some inroads, with some sectors pioneering alternative methods and scientists highlighting its shortcomings.A ...

Though prescribing climate-friendly inhalers is environmentally sound, some experts warn certain patients may be overlooked.

Most people don't enjoy getting shots for treatments or vaccines. So, researchers are working to create more medicines, such as those made from messenger RNA (mRNA), that can be sprayed and inhaled. A ...

GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), following a string of exits by companies including Pfizer, UCB, WuXi AppTec and ...

The association added that it would review the proposed order and submit comments accordingly. Tylenol maker Kenvue, GSK, ...

Teva Pharmaceutical Industries Ltd. argued Friday the Federal Circuit should reverse a district judge’s too-narrow interpretation of the statutory definition for “drug” adopted when striking five of ...

We’re pleased to present the 2024 Top 50 State Lobbyists. Featured Article: Championing Inclusivity: Expanding Pathways to ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Involves transaction of at least 0.5% of the listed shares of a company. What was Glaxosmithkline Pharmaceuticals Ltd share price previously? Glaxosmithkline Pharmaceuticals Ltd share price was ...